The Ceiling Didn't Get Higher. It Got Narrower.

A few months ago, I argued that the floor was rising across pharma field roles—clinical fluency, data command, disease-state depth, scientific preparation. The capabilities that used to separate people were becoming closer to baseline as AI made information easier to access, summarize, and synthesize.

That piece was about the floor. But it left a question open:

If the floor keeps rising, what happens to the ceiling?

So I posed the question on LinkedIn:

If AI is raising the floor, has it changed the ceiling?

I asked because I could already feel the tension showing up in conversations with pharma and biotech professionals. People were not only asking whether AI would replace parts of the work. They were asking something more uncomfortable: if everyone can prepare faster, summarize faster, draft faster, and sound more fluent, what actually separates people now?

The intuitive answer is that the ceiling rises with the floor—that everything simply shifts up and the bar gets higher. But I do not think that is what the market is showing.

Look at what is happening across pharma in 2026. Takeda announced a transformation program expected to affect roughly 4,500 roles as part of a broader restructuring effort focused on centralizing corporate functions, reducing management layers, simplifying operations, and lowering costs. Novartis confirmed roughly 58 cuts tied to its U.S. Medical Affairs team. Across the sector, the pattern is hard to miss: fewer layers, leaner teams, more restructuring, and more pressure on whoever remains.

Now place that alongside what the industry says it wants more of. As HCPs and healthcare systems gain more AI-powered decision support, field teams do not become less important—the expectation changes. The value is no longer simply delivering more information; it is delivering more precise, context-aware support. Deeper scientific expertise. Better interpretation. More relevant engagement. More judgment in the moment.

Put those two realities next to each other:

→ Companies are removing layers and cutting headcount.

→ The market wants deeper judgment and context from the people who remain.

That is not just a higher ceiling. It is a narrower one.

I saw the same tension show up in the comments on a recent post I wrote about a Medical Strategist role that seemed to compress an entire org chart into one position. What stood out was not that people rejected broad capability—most did not. Many acknowledged that pharma increasingly needs people who can operate across science, strategy, operations, stakeholders, and business context.

The pushback was different. It was about compression without capacity, capability without compensation, responsibility without sustainability. One person pointed out that many professionals still retained inside biopharma are already stretched beyond their formal job descriptions. Evelyn Shen called it a "Swiss Army knife" role across multiple departments. And one comment captured the distinction well: efficiency may keep progressing, but capacity is a different discussion.

That is the part organizations often miss. AI may increase capacity in some areas—it can help people prepare faster, synthesize faster, and produce faster—but it does not erase the friction of the work. Client expectations, competing priorities, stakeholder management, timelines, context switching, decision fatigue, and business risk all remain. A job description can list responsibilities, but the actual work multiplies complexity.

That is why this matters. The market is not just raising expectations; it is concentrating complexity. And that changes what the ceiling actually is.

Here is the misread. When the floor rises, many professionals assume the ceiling rises too. They assume the path is the same, just steeper, so they climb harder—more certifications, more preparation, more tools, more coverage, more output, more "strategic" language.

But "higher" assumes the ceiling is simply more of the same thing. I do not think it is. The ceiling is now measured by something different.

The floor still rewards knowing more—preparing more, covering more, producing more. AI can now assist with much of that faster. But the ceiling rewards interpretation: knowing which signal matters, which comment is noise, what not to act on, when the market is shifting before the data fully shows it, and how to translate scientific insight into business relevance without losing scientific integrity.

Those are not two levels of the same ladder. They are two different ladders. And many people are working harder on the one AI just made less differentiating.

This is where experienced professionals still have leverage—not because they know more facts, but because they should have more context, more pattern recognition, more judgment, and a stronger ability to understand what the information actually means. One Medical Affairs leader responding to my post, Dr. Erum Banday, captured this well: the game was never about who reads fastest; it was about who judges best.

That is the ceiling now—authority in interpretation. Not just access to information, accumulation of experience, or years in role.

For the individual, this matters. If companies are cutting layers and raising expectations for whoever remains, out-preparing the floor is not enough. The separation comes from judgment, context, signal detection, and decision impact. This is not simply knowing more, but knowing what the knowing means.

For the function, this matters too. If organizations flatten teams to reduce cost while writing job descriptions that stack five capabilities into one role, they are raising the floor and narrowing the ceiling at the same time. Then they call it a talent shortage. But sometimes it is not a talent shortage. It is a signal problem. Organizations are selecting for accumulation and hoping for judgment, and those are different things.

A person can be busy, capable, and experienced without being clearly positioned as someone who improves decisions. A role can look efficient on paper while creating retention, performance, and business-continuity risk in practice. A team can reduce layers and still increase complexity.

That is the re-leveling. The floor is rising because baseline capability is becoming easier to access. The ceiling is narrowing because organizations are concentrating complexity into fewer roles. And the differentiator is no longer just experience, it is judgment.

This is why some experienced professionals are struggling in today's market. Not because they lack value, but because they are still positioning themselves around the old signals of years, titles, responsibilities, therapeutic expertise, launch experience, KOL engagement. Those things still matter, but they may no longer be enough to separate someone in a market where more candidates can sound prepared, roles are more compressed, and fewer people are being asked to carry more.

The better question is no longer simply: Am I qualified?

The better question is: Can the market see the level of judgment I actually bring?

Can it see how I think? What I notice that others miss? How I interpret complexity? What decisions improve because I am in the room?

The ceiling did not simply get higher. It got narrower. Fewer people reach it, not because it climbed, but because many are still competing on the floor while the floor keeps moving underneath them.

Which means that for the few who stop accumulating and start interpreting, the top may be more open than it looks.

The roles are being cut. The judgment is not.

P.S. If you have been climbing the floor harder and wondering why it is not landing you in the room you want to be in, it may not be an effort problem. It may be an axis problem: you are trying to prove value on a measure the market no longer rewards the same way.

This is the work I am reopening Position to Lead for in August.